Health & Fitness
Health and Fitness
Health and Fitness
Tue, August 11, 2009
[ Tue, Aug 11th 2009
] - Market Wire
[ Tue, Aug 11th 2009
] - Market Wire
[ Tue, Aug 11th 2009
] - Market Wire
[ Tue, Aug 11th 2009
] - Market Wire
Mon, August 10, 2009
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
[ Mon, Aug 10th 2009
] - Market Wire
Fri, August 7, 2009
[ Fri, Aug 07th 2009
] - Market Wire
Thu, August 6, 2009
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
[ Thu, Aug 06th 2009
] - Market Wire
Oncothyreon announces webcast of second quarter 2009 financial results conference call
SEATTLE, Aug. 6 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it intends to release its second quarter and year end 2009 financial results on Wednesday, August 12, 2009 after the close of the U.S. and Canadian markets. Following the release, Oncothyreon's management expects to discuss these financial results and give a general business update in a conference call at 4:30 p.m. EST. The discussion is planned for a live webcast and can be accessed at[ www.oncothyreon.com ] under the "News & Events" section. It is expected that the archive of the webcast will be available approximately one hour after completion of the discussion and will be posted on the Oncothyreon website for 30 days. About Oncothyreon Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit [ www.oncothyreon.com ].
For further information: Investor and Media Relations Contact: Julie Rathbun, Rathbun Communications, (206) 769-9219, [ ir@oncothyreon.com ]
Contributing Sources
Similar Health and Fitness Articles
[ Tue, Aug 04th 2009
] - Market Wire
[ Tue, Aug 04th 2009
] - Market Wire
[ Mon, Aug 03rd 2009
] - Market Wire
[ Mon, Jun 15th 2009
] - Market Wire
[ Sat, May 30th 2009
] - Market Wire
[ Wed, May 20th 2009
] - Market Wire
[ Mon, May 18th 2009
] - Market Wire
[ Mon, May 18th 2009
] - Market Wire
[ Mon, Feb 09th 2009
] - Market Wire